Lastest from Businesswire

Subscribe to Lastest from Businesswire feed Lastest from Businesswire
Business Wire - The global leader in news distribution
Updated: 2 hours 40 min ago

American Strategic Investment Co. Announces Release Date for Second Quarter Results

Fri, 07/25/2025 - 06:09
NEW YORK--(BUSINESS WIRE)--American Strategic Investment Co. (NYSE: NYC) (“ASIC” or the “Company”) announced today it will release its financial results as of, and for the second quarter ended June 30, 2025, on Friday, August 8, 2025, before the New York Stock Exchange open. The Company will also host a webcast and conference call the same day at 11:00 a.m. ET to review results and provide commentary on business performance. Dial-in instructions for the conference call and the replay are outlin

Industry-focused Specialist IT/ITES Firm eClerx Delivers Strong Q1 FY26 Performance

Fri, 07/25/2025 - 06:09
MUMBAI, India--(BUSINESS WIRE)-- #IT--Industry-focused specialist IT/ITES firm eClerx delivers strong Q1 FY26 performance

Temenos Recognized by CNBC as One of the World’s Top Fintech Companies

Fri, 07/25/2025 - 03:09
GRAND-LANCY, Switzerland--(BUSINESS WIRE)--Temenos (SIX: TEMN), a global leader in banking technology, announced it has been named in CNBC’s list of the World’s Top Fintech Companies for 2025 in the Enterprise Fintech category. The prestigious annual ranking, developed in partnership with market research firm Statista, recognizes the most impactful fintech companies driving transformation across financial services. Temenos was selected following a comprehensive evaluation of more than 2,000 glo

Almirall H1 2025 Results

Fri, 07/25/2025 - 03:09
BARCELONA, Spain--(BUSINESS WIRE)--Almirall, S.A. (ALM) a global biopharmaceutical company based in Barcelona, today announced its financial results for the first half of 2025. The company continued to deliver strong sales growth in H1 2025, primarily driven by its dermatology business in Europe. Total Net Sales increased by 12.7% to €560.5 million, while EBITDA increased by 16.6% year-on-year to €121.8 million driven by higher sales growth and a gross profit of 65.5%. The European dermatology

Pages